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ABSTRACT
A 60-year-old man with prostatic adenocarcinoma and an
enhancing left-sided renal mass underwent successful
combined robotic radical prostatectomy and robotic rad-
ical nephrectomy. We describe the initial report of this
combined robotic procedure to remove 2 synchronous
urological malignancies and describe our technique. An
analysis was conducted of the operating room and post-
anesthesia care unit charges of this procedure compared
with the 2 procedures performed independently.
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phrectomy.
INTRODUCTION
The adoption of robotic-assisted laparoscopic prostatec-
tomy (RALP) has permitted the performance of concurrent
robotic procedures with a minimal increase in morbidity.
Previous cases of RALP combined with robotic partial
nephrectomy1 and nephroureterectomy2 have been re-
ported. To the best of our knowledge, we present the first
case of RALP combined with robotic radical nephrectomy.
CASE REPORT
A 60-year-old man with no significant prior medical or
surgical history was referred for an elevated PSA of 8.4ng/
dL. A left-sided prostatic nodule (T2a) was palpable upon
digital rectal examination. Prostate biopsy revealed pros-
tatic adenocarcinoma in 2 of 12 core biopsies. Left lateral
apex core biopsy showed Gleason 437 adenocarci-
noma involving 70% of the sample, and left mid gland
core biopsy showed Gleason 336 adenocarcinoma
involving approximately 5% of core tissue. A bone scan
was negative. A staging computed tomography (CT) scan
incidentally revealed a 4-cm heterogeneously enhancing
centrally located mass in the mid pole of his left kidney,
suggestive of renal cell carcinoma (Figure 1). Urine cy-
tology was negative. His serum creatinine was 1.0mg/dL.
The patient was consulted regarding the various treatment
options available to him for both malignancies. He was
most interested in radical prostatectomy for his prostate
cancer and partial nephrectomy for the renal mass. We
presented the possibility of being able to perform a com-
bined robotic procedure for the excision of both the
prostate and the renal mass. The patient was receptive of
the benefits of a definitive combined procedure due to the
potential for reduced morbidity compared with 2 inde-
pendent procedures. Eliminating the inconvenience and
cost associated with 2 independent hospital admissions
was a major factor in his decision.
The patient was thus consented for a combined RALP and
robotic partial nephrectomy, with the understanding of
the possibility of conversion to a radical nephrectomy if
intraoperative assessment necessitated it.
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CASE REPORTMETHODS
Robotic Prostatectomy
The procedure began as a standard robotic prostatectomy.
Following the induction of general anesthesia, the patient
was placed in the lithotomy position and prepped and
draped in standard fashion. Pneumoperitoneum was
achieved with a Veress needle. Port placement is depicted
in Figure 2. A 12-mm trocar was inserted into the perito-
neal cavity via a supraumbilical incision. Two 8-mm ro-
botic trocars were placed lateral to the rectus sheath in
each lower quadrant, and an additional 8-mm robotic
trocar was placed in the left lateral flank. A 12-mm trocar
was placed in the right pararectal area superior to the
umbilicus, and another 12-mm trocar was placed in the
extreme right lateral flank.
The patient was placed in a steep Trendelenburg position,
and the da Vinci S surgical robot (Intuitive Surgical,
Sunnyvale, CA) was docked. A standard robotic radical
prostatectomy with bilateral “curtain”-type nerve sparing
and bilateral pelvic lymph node dissection was per-
formed.3 The prostate was placed in an EndoCatch sac
(Covidien AG, Norwalk, CT) and positioned in the pelvis
to be removed at the conclusion of the operation. All
trocars were then removed under laparoscopic guidance,
and the port sites were covered with sterile adhesive
dressings, maintaining the possibility of their reuse during
the next stage of the procedure.
Robotic Nephrectomy
The patient was then moved to the left flank position and
secured to the table, which was flexed and slightly ro-
tated. All pressure points were padded. The patient was
reprepped and draped in a sterile fashion. A 5-mm trocar
was reintroduced into the periumbilical incision for the
purpose of reobtaining pneumoperitoneum. Two trocar
sites from the previous procedure were reused (Figure
2). The 5-mm trocar in the periumbilical incision was
swapped for a 12-mm trocar as an assistant port, and an
8-mm robotic trocar was introduced at the previously
utilized left lower quadrant site. Additionally, 2 new tro-
cars were inserted: an 8-mm robotic trocar in the subcostal
region and a 12-mm trocar lateral to the umbilicus in the
midclavicular line as a camera port. The adhesive dress-
ings on the port sites that were not reused successfully
maintained the pneumoperitoneum.
The robot was then docked, and the surgery was begun
by opening the white line of Toldt from the level of the
upper sigmoid to the splenic flexure. The renal hilum was
exposed, and dissection continued in a cephalad direc-
tion. Further dissection exposed the renal vein and the
adrenal and gonadal vessels. The gonadal vein and a
lumbar vein coursing posteriorly were clipped and di-
vided. The renal artery and vein were identified and dis-
sected free from the surrounding tissue.
Figure 1. Computed tomographic (CT) scan showing a 4-cm
heterogeneously enhancing centrally located mass in the mid
pole of the left kidney.
Figure 2. Port placement for robotic prostatectomy.
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into the abdomen to aid in the assessment of the renal
mass. Careful inspection revealed that the endophytic
mass appeared to be invading into the collecting system
and occupied approximately 25% to 30% of the kidney
volume. It was centrally located, and there was concern
regarding our ability to safely perform renorrhaphy. Given
the location and potential level of invasion of the tumor,
we felt that performing a partial nephrectomy would not
be feasible, and the decision was made to proceed with a
radical nephrectomy. This was discussed intraoperatively
with the patient’s family, who concurred.
The renal artery, vein, and ureter were subsequently clipped
and divided. The adrenal gland was dissected free and left in
situ. The kidney and perinephric fat were dissected from the
retroperitoneum outside of Gerota’s fascia and placed in an
EndoCatch sac. The periumbilical incision was extended
around the umbilicus, and both the prostatectomy and ne-
phrectomy specimens were removed via this incision. The
fascia of the extraction excision and remaining 12-mm ports
was closed with O polyglactin suture in a running fashion. A
suction drain was placed in the left lower quadrant as per the
protocol following prostatectomy.
RESULTS AND FOLLOW-UP
The total time of the patient under anesthesia for the
procedure was 300 minutes, with an operative time of 278
minutes (prostatectomy, 120 minutes; nephrectomy, 158
minutes) and 22 minutes required for repositioning. Esti-
mated blood loss was 200mL (prostatectomy, 100mL; ne-
phrectomy, 100mL). Postoperatively, the patient’s hospital
course was unremarkable, and he was discharged on
postoperative day 2. Serum creatinine prior to discharge
was 1.3mg/dL. Final histopathology of the prostate re-
vealed Gleason 347 prostatic adenocarcinoma, stage
pT2c. Surgical resection margins and lymph nodes were
negative. Final histopathology report of the kidney dem-
onstrated a 4.0-cm clear-cell renal-cell carcinoma,
Fuhrman grade 2. The mass did not invade the renal sinus
fat, or renal capsule, rendering it stage pT1a. Surgical
resection margins were negative.
The patient had no postoperative complications and did
not require readmission. His Foley catheter was removed
on postoperative day 8. He was seen in follow-up on
postoperative day 15, at which point he had fully regained
continence (he had stopped using pads) and was having
spontaneous erections. Serum PSA was undetectable. A
photograph of his abdomen at this follow-up visit is
shown in Figure 2.
Total operating room (OR) charges for this procedure, in-
cluding postanesthesia care unit (PACU) charges, were
$19,017. This compares favorably for the 2 procedures per-
formed independently. A representative, uncomplicated
RALP at Mount Sinai resulted in $13,397 in OR and PACU
charges, while a converted robotic partial to radical nephrec-
tomy led to $16,147 in charges. Thus when performed inde-
pendently, the 2 procedures resulted in $29,544 charges,
$10,527 more than the combined approach.
DISCUSSION
The management of multiple primary urological malig-
nancies with combined minimally invasive procedures is
not unprecedented,4–6 yet reports of combined robotic
procedures in the treatment of urologic malignancies is
limited. Cases of robotic-assisted radical prostatectomy
combined with partial nephrectomy1 and nephroureterec-
tomy have been previously reported.2 To the best of our
knowledge, this is the first documented report of a com-
bined robotic radical prostatectomy and robotic radical
nephrectomy for the treatment of primary prostatic ade-
nocarcinoma and renal cell carcinoma.
Robotic-assisted laparoscopic surgery offers patients a
minimally invasive option for the treatment of their ma-
lignancy. Combined procedures offer the further advan-
tage of avoiding the morbidity associated with multiple
operations and eliminating the time, cost, and convales-
cence associated with a second operative procedure and
hospital admission. As many of the same trocar sites (2 of
4 for the nephrectomy) and the extraction site can be used
for both procedures, the additional morbidity compared
with one procedure alone is minimal.
These benefits of combined robotic procedures are not
without possible limitations and drawbacks. As the oper-
ative length is significantly longer (5 hours in this case)
than either procedure alone, the patient must be able to
tolerate general anesthesia for a greater amount of time.
This could conceivably lead to a longer postoperative
recovery. The steep Trendelenburg necessary to per-
form a RALP and the flexed lateral decubitus position of
a nephrectomy result in the patient’s head being below
his heart. Prolonged surgeries in this position increase
the risk of complications, especially those related to
venous stasis, such as deep venous thrombosis and
pulmonary embolism, and even compartment syn-
drome of the leg.7 Ophthalmologic complications due
to prolonged steep Trendelenburg and a resultant in-
crease in intraocular pressure have been reported, al-
though only in cases longer than 5 hours.8 In this case,
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cedure, briefly returning to a neutral position. Such a
“positional holiday” may be adequate to alleviate the
risks of a prolonged head-down position.
Given the limited number of combined robotic procedures
that have been documented, the true impact of the potential
risks and benefits has not been described. However, consid-
ering that both procedures are well described and were
performed in a timely manner, it is unlikely that a higher
complication rate would be expected than for either surgery
alone. Larger case series will aid in defining the extent of the
risks and benefits of combined procedures. Such case series,
however, will likely take a long time to accrue given the
rarity of 2 synchronous urologic malignancies.
A technical point that merits discussion is the issue of port
placement in combined robotic procedures. Through our
port placement strategy, we were able to use an 8-mm
robotic trocar site in the left lower quadrant and a perium-
bilical 12-mm trocar site for both procedures (Figure 2).
Therefore, only 8 port sites were needed for the completion
of both procedures as opposed to the creation of 9 or 10 port
sites had the procedures been performed separately. This
presumably reduces operative morbidity and pain.
The reuse of port sites requires planning by the surgical
team, especially if different surgeons are performing the
different surgeries. The strategy for potential reuse of port
sites should be a part of the preoperative discussion for
any combined robotic procedure. Consideration of the
ideal port placement for the second procedure should be
given when ports are being placed for the first procedure.
Ideally, the port sites should be chosen that permit the
safe performance of both procedures through the same
ports without compromising the ability to perform either.
This often necessitates slightly modifying standard port
placement for the first procedure. For example, we placed
our 8-mm left lower quadrant incision slightly caudal to
our normal placement to increase the triangulation for the
nephrectomy. Such modification may increase intraoper-
ative efficiency and minimize the necessity of making
additional abdominal incisions.
The intraoperative decision to convert from partial to
radical nephrectomy was a critical step in our procedure.
It should be stressed that this decision was made for
oncologic and not procedural reasons. Given recent re-
ports associating lower rates of overall mortality with
nephron-sparing surgery (NSS) compared with radical ne-
phrectomy in the treatment of small renal malignancies,9
we perform NSS whenever oncologically feasible. How-
ever, the CT revealed a centrally located endophytic mass,
close to the collecting system, and intraoperative ultra-
sound suggested that it invaded the collecting system. At
the time, we felt that the best course of action for the
patient was to proceed in favor of a radical nephrectomy,
and the patient’s family concurred.
Robotic radical nephrectomy has been shown to be safe
and effective in the treatment of renal malignancy.10 The
same instruments are used for robotic radical and partial
nephrectomy, thus the required instrumentation was read-
ily available. Conversion to a laparoscopic or open pro-
cedure would have unnecessarily prolonged the case
without a significant benefit and would have required the
use of additional instruments. Accordingly, little consider-
ation was given to these options.
The financial benefits of combining the procedures are
substantial. Our approach likely resulted in a cost savings
of over $10,000 in OR and PACU charges compared with
2 independent procedures. When including the additional
costs of an additional hospitalization and the associated
services (laboratory, pharmacy, and other services) the
savings would be even greater.
CONCLUSION
We present a successful combined robotic prostatectomy
and robotic radical nephrectomy for the treatment of syn-
chronous prostatic adenocarcinoma and clear-cell renal cell
carcinoma. We believe that in the carefully selected patient,
combined robotic procedures can offer many benefits. Such
benefits include reduced morbidity and a shortened hospi-
talization, convalescence and reduced cost compared with 2
separate procedures and hospital admissions. The potential
risks involved in combined operations may be minimized
through careful preoperative planning and execution.
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